MM120 for Generalized Anxiety Disorder
Do you struggle with anxiety? You are not alone. We are doing research for a new investigational treatment option to see if it is effective in improving anxiety. If you suffer from anxiety, you may be eligible to participate.
About This Clinical Trial
What is being tested? MM120 is a study drug that researchers believe could have possible benefits that may improve your anxiety symptoms.
Does it cost to participate? It does not cost anything to participate in the study. If you participate in the study, you will be compensated for travel and your time.
Why participate? Participation in a clinical study can help researchers learn more and discover new treatments for the disease that is being studied. If you take part, other people with anxiety may be helped by the research.
What to Expect as a Trial Participant
- If you qualify for participation, you will receive either the study drug or placebo, which is an active drug that looks like the study drug but contains no active ingredients.
- There is a 40 week extension phase of the study where eligible participants can receive study drug.
- The study lasts approximately 56 weeks.
- You will attend in-person visits and remote visits throughout your participation.
- Taking part is completely voluntary and you may discontinue participation at any time.

Am I Eligible?
You may be eligible to participate if you are:
- Aged 18 to 74 years old
- Experiencing anxiety
- Willing to use a highly effective method of birth control throughout participation
- Willing to stop all medications affecting mood
Ready to Take the Next Step?
Call for information on Psychedelic-Assisted Clinical Trials: 310-996-8966
Schedule a consultant and find out if participating in a clinical trial or other care option is right for you.
Crisis Support Disclaimer
Notice: If you or someone you know is in crisis, call the National Suicide Prevention Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line (text HELLO to 741741).